Market Value277,340,000
Total Holdings46
File Date2021-05-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PMVP / PMV Pharmaceuticals, Inc.
KURA / Kura Oncology, Inc.
IOVA / Iovance Biotherapeutics, Inc.
AXSM / Axsome Therapeutics, Inc.
CYCC / Bio Green Med Solution, Inc.
SAGE / Sage Therapeutics, Inc.
RNA / Atrium Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
RAPT / RAPT Therapeutics, Inc.
SURF / Surface Oncology Inc
US92731L1145 / Vincerx Pharma, Inc.
EPIX / ESSA Pharma Inc.
RETA / Reata Pharmaceuticals Inc - Class A
VINC / Vincerx Pharma, Inc.
TRIL / Tidal Trust II - Defiance Trillion Dollar Club Index ETF
CCCC / C4 Therapeutics, Inc.
ANNX / Annexon, Inc.
BHVN / Biohaven Ltd. Call
KRTX / Karuna Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
CNCE / Concert Pharmaceuticals Inc
CPRX / Catalyst Pharmaceuticals, Inc.
ATHA / LeonaBio, Inc.
SELB / Selecta Biosciences Inc
JYAC / Jiya Acquisition Corp - Class A
BLSA / BCLS Acquisition Corp - Class A
CRIS / Curis, Inc.
STOK / Stoke Therapeutics, Inc.
ONCR / Oncorus, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
ALDX / Aldeyra Therapeutics, Inc.
CMRX / Chimerix, Inc.
SEEL / Seelos Therapeutics, Inc.
VSTM / Verastem, Inc.
NVAX / Novavax, Inc.
LRMR / Larimar Therapeutics, Inc.
ISEE / IVERIC bio Inc
CLSD / Clearside Biomedical, Inc.
AVDL / Avadel Pharmaceuticals plc
SNDX / Syndax Pharmaceuticals, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
HSAQ / Health Sciences Acquisitions Corp 2
VTGN / Vistagen Therapeutics, Inc.
CBIO / Crescent Biopharma, Inc.
XENE / Xenon Pharmaceuticals Inc.
EYPT / EyePoint, Inc.
MRTX / Mirati Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
ALT / Altimmune, Inc.
CBAY / CymaBay Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
ACRS / Aclaris Therapeutics, Inc.
ETNB / 89bio, Inc.
WVE / Wave Life Sciences Ltd.
REPL / Replimune Group, Inc.
PRAX / Praxis Precision Medicines, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
MRSN / Mersana Therapeutics, Inc.